Hard-fought approval to commercial flop: Uniqure pulling plug on first gene therapy – BioWorld Online
|
Hard-fought approval to commercial flop: Uniqure pulling plug on first gene therapy
BioWorld Online LONDON – Uniqure NV is ditching its world-first gene therapy Glybera and will not renew the European license when it expires on Oct. 25. If that is a sad end to one of the most protracted drug development sagas in history, it undoubtedly sets a bad … |
The San Diego Union-Tribune |
For stem cell treatments, patients, doctors, scientists must collaborate
The San Diego Union-Tribune California’s stem cell agency stresses collaboration in public outreach. |
|
Gene Therapy Drug Being Pulled for Lack of Customers (Reuters via NBC News)
MedPage Today A drug company is pulling the Western world’s first gene therapy drug from the market — because no one wants to buy it. Only one patient has been treated via commercial purchase of Glybera, a drug for a rare blood disorder, since it was approved by … |
|
Gene Therapy Drug Being Pulled for Lack of Customers (Reuters via NBC News)
MedPage Today A drug company is pulling the Western world’s first gene therapy drug from the market — because no one wants to buy it. Only one patient has been treated via commercial purchase of Glybera, a drug for a rare blood disorder, since it was approved by … |
Channel3000.com – WISC-TV3 |
Stem cell research: The hope and the hype
Channel3000.com – WISC-TV3 MADISON, Wis. – In research labs at the McPherson Eye Research Institute, work is being done to find ways to use stem cells to halt and possibly reverse vision loss caused by blinding diseases. “I have a tremendous amount of hope,” said Dr. David Gamm, … |
|
Designer yeast just the start of a synthetic biology revolution
ABC Technology and Games Synthetic biology promises to revolutionise everything from the fuel we use, to the clothes we wear. In Australia the science has been used to create a raspberry flavoured glass of Chardonnay, while work continues to build the world’s first fully … |
|
Advancing Technology – Hemophilia Market Growing Popularity of Gene Therapy : Pfizer Inc., Bayer Group, Shire PLC …
Medgadget (blog) The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. |
FierceBiotech |
‘Priming’ protein boosts stem cell response to injury, promotes healing
FierceBiotech Stanford University scientists have identified a protein that, given before an injury, boosts stem cell response and improves healing. “Priming” with this protein, called hepatocyte growth factor activator (HGFA), could eventually speed recovery in … |